Home
About Us
Management
Thrust Areas
Disclaimer
Dr Boominathan’s Quotes
Ideas
Bio-Med Ideas
Ideas for Free
Bio-Pharma/Med Ideas
Audience Profile
Bio-Medical Ideas-7,900+
Bio-Med Res Grants Aid
p63 and p73 Community
How p63/p73/p53 Field Progresses
Noble Laureate’s work tracked by GBMD
Ideas were viewed by World’s Best 10 Universities
Submit your Ideas
miRNA Therapeutics
Intellectual Property Development
Licensing Opportunities
Partnerships
Investor opportunities
Educational Tools
Scientific Resources
Research
Research Focus
Research Themes
Research – II
Dr Boomi’s Contributions (Res)
Dr Boomi’s caliber (Sci)
Conference publications
Research Publications
Research Training
Ph.D/M.D/M.Tech Mentor
What Scientists Saying
Peer/Manuscript Review
Press/Media Release
Conferences/Meetings
B-MERIIT
Introduction
Founder
What We Assure
M.S program
M.S in Molecular Cancer Biology
M.S in Stem cell Biology & Regenerative Medicine
M.S in Mol. Medicine
M.S in Genome Biology
M.S in Bio-Medical Sciences
Model Building & Model Laboratory
Investor opportunities
Logo
Career guidance
Admission Details
Registration
Terms and conditions
Career/Opportunities
Contact Us
Insights into innate immune response: Tumor suppressor p53 homologue TAp63 increases the expression of interferon (IFN)-induced protein ISG15 via up regulation of its target gene, 11/January/2014, 6.06 am
Therapeutic insights into Hepatitis and Hepatocellular carcinoma: Tumor suppressor p53 homologue TAp63 inhibits Hepatitis C virus infection via up regulation of its target gene, 11/January/2014, 5.59 am
January 11, 2014
Cancer therapy for Renal cell carcinoma: Tumor suppressor p53 suppresses the expression of oncogenic NEDD9 via up regulation of its target gene, 11/January/2014, 6.33 am
January 11, 2014
0
Published by
admin_auro
at
January 11, 2014
Categories
Uncategorized
Tags
admin_auro
Comments are closed.
